Cargando…

The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling

SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their m...

Descripción completa

Detalles Bibliográficos
Autores principales: Merk-Ahmad, Katrin, Bein, Julia, Scharf, Sonja, Schäfer, Hendrik, Bexte, Tobias, Ullrich, Evelyn, Loth, Andreas G., Flinner, Nadine, Senff, Tina, Schneider, Olga, Hansmann, Martin-Leo, Piel, Matthieu, Häupl, Björn, Oellerich, Thomas, Donnadieu, Emmanuel, Hartmann, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296629/
https://www.ncbi.nlm.nih.gov/pubmed/37370838
http://dx.doi.org/10.3390/cancers15123226
_version_ 1785063694755954688
author Merk-Ahmad, Katrin
Bein, Julia
Scharf, Sonja
Schäfer, Hendrik
Bexte, Tobias
Ullrich, Evelyn
Loth, Andreas G.
Flinner, Nadine
Senff, Tina
Schneider, Olga
Hansmann, Martin-Leo
Piel, Matthieu
Häupl, Björn
Oellerich, Thomas
Donnadieu, Emmanuel
Hartmann, Sylvia
author_facet Merk-Ahmad, Katrin
Bein, Julia
Scharf, Sonja
Schäfer, Hendrik
Bexte, Tobias
Ullrich, Evelyn
Loth, Andreas G.
Flinner, Nadine
Senff, Tina
Schneider, Olga
Hansmann, Martin-Leo
Piel, Matthieu
Häupl, Björn
Oellerich, Thomas
Donnadieu, Emmanuel
Hartmann, Sylvia
author_sort Merk-Ahmad, Katrin
collection PubMed
description SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their migration capacity neither in microfluidics microchannels, 3D collagen gel or primary human lymphoid tissue. In contrast, RHOA-G17V overexpressing cells from the HH cell line presented increased numbers of cells surrounded by cleaved collagen. Primary AITL cases showed a correlation between RHOA-G17V mutation allele frequency and collagen fibrosis of the tissue, suggesting that mechanisms leading to extracellular matrix degradation contribute to the early spread of AITL tumor cells. ABSTRACT: Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the RHOA mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because RHOA is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did not exhibit enhanced motility compared to empty-vector-transfected cells in microchannels, a 3D collagen gel, or primary human lymphatic tissue. Cells of the HH cell line expressing RHOA-G17V had an increased number of cells with cleaved collagen compared with the empty-vector-transfected cells. Therefore, we hypothesized that the early spread of AITL tumor cells may be related to remodelling of the extracellular matrix. Accordingly, we observed a significant negative correlation between the relative area of collagen in histological sections from 18 primary AITL and the allele frequency of the RHOA-G17V mutation. In conclusion, our results suggest that the characteristic presentation of AITL with early, widespread dissemination of lymphoma cells is not the result of an enhanced migration capacity due to the RHOA-G17V mutation; instead, this feature may rather be related to extracellular matrix remodelling.
format Online
Article
Text
id pubmed-10296629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102966292023-06-28 The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling Merk-Ahmad, Katrin Bein, Julia Scharf, Sonja Schäfer, Hendrik Bexte, Tobias Ullrich, Evelyn Loth, Andreas G. Flinner, Nadine Senff, Tina Schneider, Olga Hansmann, Martin-Leo Piel, Matthieu Häupl, Björn Oellerich, Thomas Donnadieu, Emmanuel Hartmann, Sylvia Cancers (Basel) Article SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their migration capacity neither in microfluidics microchannels, 3D collagen gel or primary human lymphoid tissue. In contrast, RHOA-G17V overexpressing cells from the HH cell line presented increased numbers of cells surrounded by cleaved collagen. Primary AITL cases showed a correlation between RHOA-G17V mutation allele frequency and collagen fibrosis of the tissue, suggesting that mechanisms leading to extracellular matrix degradation contribute to the early spread of AITL tumor cells. ABSTRACT: Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the RHOA mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because RHOA is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did not exhibit enhanced motility compared to empty-vector-transfected cells in microchannels, a 3D collagen gel, or primary human lymphatic tissue. Cells of the HH cell line expressing RHOA-G17V had an increased number of cells with cleaved collagen compared with the empty-vector-transfected cells. Therefore, we hypothesized that the early spread of AITL tumor cells may be related to remodelling of the extracellular matrix. Accordingly, we observed a significant negative correlation between the relative area of collagen in histological sections from 18 primary AITL and the allele frequency of the RHOA-G17V mutation. In conclusion, our results suggest that the characteristic presentation of AITL with early, widespread dissemination of lymphoma cells is not the result of an enhanced migration capacity due to the RHOA-G17V mutation; instead, this feature may rather be related to extracellular matrix remodelling. MDPI 2023-06-17 /pmc/articles/PMC10296629/ /pubmed/37370838 http://dx.doi.org/10.3390/cancers15123226 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Merk-Ahmad, Katrin
Bein, Julia
Scharf, Sonja
Schäfer, Hendrik
Bexte, Tobias
Ullrich, Evelyn
Loth, Andreas G.
Flinner, Nadine
Senff, Tina
Schneider, Olga
Hansmann, Martin-Leo
Piel, Matthieu
Häupl, Björn
Oellerich, Thomas
Donnadieu, Emmanuel
Hartmann, Sylvia
The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title_full The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title_fullStr The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title_full_unstemmed The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title_short The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
title_sort rhoa mutation g17v does not lead to increased migration of human malignant t cells but is associated with matrix remodelling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296629/
https://www.ncbi.nlm.nih.gov/pubmed/37370838
http://dx.doi.org/10.3390/cancers15123226
work_keys_str_mv AT merkahmadkatrin therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT beinjulia therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT scharfsonja therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT schaferhendrik therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT bextetobias therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT ullrichevelyn therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT lothandreasg therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT flinnernadine therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT senfftina therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT schneiderolga therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hansmannmartinleo therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT pielmatthieu therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hauplbjorn therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT oellerichthomas therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT donnadieuemmanuel therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hartmannsylvia therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT merkahmadkatrin rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT beinjulia rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT scharfsonja rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT schaferhendrik rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT bextetobias rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT ullrichevelyn rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT lothandreasg rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT flinnernadine rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT senfftina rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT schneiderolga rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hansmannmartinleo rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT pielmatthieu rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hauplbjorn rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT oellerichthomas rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT donnadieuemmanuel rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling
AT hartmannsylvia rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling